N-TproBNP as biomarker in systemic sclerosis.

about

The long-term marriage between autoimmunity and internal medicine: a homage to Manuel Carlos Dias.Scleroderma renal crisis and renal involvement in systemic sclerosis.

P2860

Q38028889-5EEC57DF-E679-455C-8345-E5BE0E8A9940 Q38957950-F6353FF5-0B8F-4523-9135-34FBCAC30D86

P2860

N-TproBNP as biomarker in systemic sclerosis.

Item

http://www.wikidata.org/entity/Q38016375

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

N-TproBNP as biomarker in systemic sclerosis.

@en

type

Item

label

N-TproBNP as biomarker in systemic sclerosis.

@en

prefLabel

N-TproBNP as biomarker in systemic sclerosis.

@en

P1476

N-TproBNP as biomarker in systemic sclerosis

@en

P2093

Antonella Murgo

http://www.w3.org/2001/XMLSchema#string

Carolina Artusi

http://www.w3.org/2001/XMLSchema#string

Silvana Zeni

http://www.w3.org/2001/XMLSchema#string

Teresa Ciavarella

http://www.w3.org/2001/XMLSchema#string

P2860

The role of natriuretic peptide testing in guiding chronic heart failure management: review of available data and recommendations for use

Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure

How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review

Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension.

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients.

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American Coll

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach.

P2888

s12016-012-8312-4

P304

292-301

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12016-012-8312-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Cecilia Beatrice Chighizola

Pier Luigi Meroni

Francesca Ingegnoli

Tommaso Schioppo

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1035228582

http://www.w3.org/2001/XMLSchema#string

P698

22669751

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

N-TproBNP as biomarker in systemic sclerosis.

about

P2860

P2860

N-TproBNP as biomarker in systemic sclerosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921